Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting

Chest

Volumn 106, Issue 3, 1994, Pages 835-841

  MacGregor, D A ^a   Butterworth IV, J F ^a   Zaloga, G P ^a   Prielipp, R C ^a   James, R ^a   Royster, R L ^a  

^a Dept of Anesthesia ^*  (United States)

Author keywords

Cardiac surgery (CABG); dobutamine; dopexamine; inotropic support (inotropy)

Indexed keywords

DOBUTAMINE; DOPEXAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; DIURESIS; DRUG MECHANISM; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE; HUMAN; NATRIURESIS; PRIORITY JOURNAL; SODIUM EXCRETION; TACHYCARDIA; URINE VOLUME;

EID: 0027941275     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.106.3.835     Document Type: Article

References (47)

1. Royster RL Butterworth JF IV Prough DS Johnston WE Thomas JL Hogan PE Preoperative and intraoperative predictors of inotropic support and long-term outcome in patients having coronary artery bypass grafting. Anesth Analg 72 1991 729 736
2. Royster RL Intraoperative administration of inotropes in cardiac surgery patients. J Cardiothorac Vasc Anesth 4 1990 17S 28S
3. Schwenzer KJ Kopel RF Hemodynamic and metabolic effects of dobutamine in 18 patients after open heart surgery. Crit Care Med 18 1990 1107 1110
4. Stoner JD III Bolen JL Harrison DC Comparison of dobutamine and dopamine in treatment of severe heart failure. Br Heart J 39 1977 536 539
5. Leier CV Heban PT Huss P Bush CA Lewis RP Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation 58 1978 466 475
6. Goldberg LI Rajfer SI Dopamine receptors: applications in clinical cardiology. Circulation 72 1985 245 248
7. Vatner SF Baig H Importance of heart rate in determining the effects of sympathomimetic amines on regional myocardial ischemia. Circ Res 45 1979 793 803
8. 2-adrenoceptors. Br J Pharmacol 85 1985 599 608
9. Foulds RA Clinical development of dopexamine hydrochloride (Dopacard) and an overview of its hemodynamic effects. Am J Cardiol 62 1988 41C 45C
10. Jaski BE Peters C Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine. Am J Cardiol 62 1988 63C 67C
11. Leier CV Binkley PF Carpenter J Randolph PH Unverferth DV Cardiovascular pharmacology of dopexamine in low output congestive heart failure. Am J Cardiol 62 1988 94 99
12. 2-adrenergic and dopaminergic agonist: haemodynamic effects following cardiac surgery. Eur Heart J 9 1988 853 858
13. Lokhandwala MF Renal actions of dopexamine hydrochloride. Clin Intensive Care 1 1990 163 174
14. Vyas S] Lokhandwala MF Role of tubular dopamine-1 receptors in the natriuretic and diuretic response to dopexamine. Pharmacologist 31 1989 378
15. Bass AS Contrasting effects of dopexamine hydrochloride on electrolyte excretion in canine kidney. J Pharmacol Exp Ther 253 1990 798 802
16. Holm S A simple sequentially rejective multiple test procedure. Scand J Stat 6 1979 65 70
17. Gold JP Roberts AJ Hoover EL Blank S Gay WA Jr Subramanian VA Effects of prolonged aortic cross-clamping with potassium cardioplegia on myocardial contractility in man. Surg Forum 30 1979 252 254
18. Swanson DK Myerowitz PD Effect of reperfusion temperature and pressure on the functional and metabolic recovery of preserved hearts. J Thorac Cardiovasc Surg 86 1983 242 251
19. Przyklenk K Kloner RA ‘Reperfusion injury’ by oxygen derived free radicals? effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circ Res 64 1989 86 96
20. Mangano DT Biventricular function after myocardial revascularization in humans: deterioration and recovery patterns during the first 24 hours. Anesthesiology 62 1985 571 577
21. Breisblatt WM Stein KL Wolfe CJ Follansbee WP Capozzi J Armitage JM Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol 15 1990 1261 1269
22. McDevitt DG In vivo studies on the function of cardiac β-adrenoceptors in man. Eur Heart J 10 suppl B 1989 22 28
23. 125I]iodocyanopindolol binding. Circ Res 53 1983 752 758
24. Stiles GL Taylor S Lefkowitz RJ Human cardiac β-adrenoceptors: subtype heterogeneity delineated by direct radioligand binding. Life Sci 33 1983 467 473
25. Buxton BF Jones CR Molenaar P Summers RJ Characterization and autoradiographic localization of β-adrenoceptor subtypes in human cardiac tissues. Br J Pharmacol 92 1987 299 310
26. 2-adrenoceptors in the human heart. Eur Heart J 10 suppl B 1989 11 21
27. 2-adrenoceptors in the human heart by chronic β-adrenoceptor antagonist treatment. Br J Pharmacol 94 1988 685 692
28. Bristow MR Port JD Hershberger RE Gilbert EM Feldman AM The 0-adrenergic receptor-adenylate cyclase complex as a target for therapeutic intervention in heart failure. Eur Heart J 10 suppl B 1989 45 54
29. Bristow MR Hershberger RE Port JD Gilbert EM Sandoval A Rasmussen R β- Adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation 82 2 suppl 1990 I12 25
30. Bristow MR The adrenergic nervous system in heart failure. N Engl J Med 311 1984 850 851
31. Feldman AM Cates AE Veazey WB Hershberger RE Bristow MR Baughman KL Increase of the 40,000 mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest 82 1988 189 197
32. Chatterjee K DeMarco T Central and peripheral adrenergic receptor agonists in heart failure. Eur Heart J 10 suppl B 1989 55 63
33. 1- and 02-adrenoceptors. Eur Heart J 10 supp B 1989 38 44
34. 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J 10 suppl B 1989 29 37
35. 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium: quantitative discrepancies with binding and adenylate cyclase stimulation. Naunyn Schmiedebergs Arch Pharmacol 335 1987 403 411
36. 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. J Cardiovasc Pharmacol 8 1986 1235 1242
37. Tinker JH Tarhan S White RD Pluth JR Barnhorst DA Dobutamine for inotropic support during emergence from cardiopulmonary bypass. Anesthesiology 44 1976 281 286
38. Piepenbrock S Reichelt W Hempelmann G Brackertz A Dragojevic D Hetzer R Hemodynamic effects of dobutamine and epinephrine in patients during coronary surgery. Thorac Cardiovasc Surg 27 1979 378 385
39. Schwenzer KJ Miller ED Jr. Hemodynamic effects of dobutamine in patients following mitral valve replacement. Anesth Analg 68 1989 467 472
40. Van Trigt P Spray TL Pasque MK Peyton RB Pellom GL Wecksler AS The comparative effects of dopamine and dobutamine on ventricular mechanics after coronary artery bypass grafting: a pressure-dimension analysis. Circulation 70 suppl I 1984 I 112-1-117
41. Westman L Jarnberg PO Effects of dobutamine on haemodynamics and renal function in patients after major vascular surgery. Acta Anaesthesiol Scand 31 1987 253 257
42. Butterworth JF IV Prielipp RC Royster RL Spray BJ Kon ND Wallenhaupt SL Dobutamine increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgery. J Cardiothorac Vasc Anesth 6 1992 535 541
43. Lokhandwala MF Barrett RJ Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications. J Auton Pharmacol 2 1982 189 215
44. Mitchell PD Smith GW Wells E West PA Inhibition of uptake-1 by dopexamine hydrochloride in vitro Br J Pharmacol 92 1987 265 270
45. Colardyn FC Vandenbogaerde JF Vogelaers DP Verbeke JH Use of dopexamine hydrochloride in patients with septic shock. Crit Care Med 17 1989 999 1003
46. Bredle DL Cain SM Systemic and muscle oxygen uptake/delivery after dopexamine infusion in endotoxic dogs. Crit Care Med 19 1991 198 204
47. Cain SM Curtis SE Systemic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine. Crit Care Med 19 1991 1552 1560